These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7700065)

  • 1. Genetics of primary hypertension.
    Ganten D; Schmidt S; Paul M
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S45-50. PubMed ID: 7700065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic rats: tools to study the function of the renin-angiotensin system.
    Bader M; Ganten D
    Clin Exp Pharmacol Physiol Suppl; 1996; 3():S81-7. PubMed ID: 8993844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transgenic rats as a model for investigation of the pathogenesis of hypertension].
    Paul M
    Z Kardiol; 1995; 84 Suppl 4():55-60. PubMed ID: 8585274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin-angiotensin system in transgenic rats: characteristics and functional studies.
    Wagner J; Ganten D
    Semin Nephrol; 1993 Nov; 13(6):586-92. PubMed ID: 8278693
    [No Abstract]   [Full Text] [Related]  

  • 5. Transgenic animals: new approaches to hypertension research.
    Mullins JJ; Ganten D
    J Hypertens Suppl; 1990 Dec; 8(7):S35-7. PubMed ID: 2095394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive hypertension and end-organ damage in a transgenic mouse line carrying the rat angiotensinogen gene.
    Xu P; Wang Y; Sterner-Kock A; Bader M; Schultheiss HP; Walther T
    J Cardiovasc Pharmacol; 2009 Jan; 53(1):38-43. PubMed ID: 19129738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
    Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics in arterial hypertension--clinical and experimental aspects.
    Hübner N; Ganten D
    Herz; 1995 Oct; 20(5):309-14. PubMed ID: 7498877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of genetic hypertension: what can we learn for human hypertension?
    Rubattu S; Struk B; Kreutz R; Volpe M; Lindpaintner K
    Clin Exp Pharmacol Physiol; 1995 Dec; 22(12):S386-93. PubMed ID: 8846502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension.
    Corvol P; Soubrier F; Jeunemaitre X
    Pathol Biol (Paris); 1997 Mar; 45(3):229-39. PubMed ID: 9296068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic rats in hypertension research.
    Wagner J; Zeh K; Paul M
    J Hypertens; 1992 Jul; 10(7):601-5. PubMed ID: 1321185
    [No Abstract]   [Full Text] [Related]  

  • 12. Dependence of angiotensin production in transgenic mice carrying either the human renin or human angiotensinogen genes on species-specific kinetics of the renin-angiotensin system.
    Fukamizu A; Takimoto E; Sugimura K; Hatae T; Seo MS; Takahashi S; Sugiyama F; Kajiwara N; Yagami K; Murakami K
    Arzneimittelforschung; 1993 Feb; 43(2A):222-5. PubMed ID: 8498968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common genetic mechanisms of blood pressure elevation in two independent rodent models of human essential hypertension.
    Friese RS; Mahboubi P; Mahapatra NR; Mahata SK; Schork NJ; Schmid-Schönbein GW; O'Connor DT
    Am J Hypertens; 2005 May; 18(5 Pt 1):633-52. PubMed ID: 15882546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A transgenic animal model: new possibilities for cardiovascular research].
    Franz WM; Frey N; Müller O; Kübler W; Katus HA
    Z Kardiol; 1995; 84 Suppl 4():17-32. PubMed ID: 8585270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated renin-angiotensin system.
    Sugiyama F; Haraoka S; Watanabe T; Shiota N; Taniguchi K; Ueno Y; Tanimoto K; Murakami K; Fukamizu A; Yagami K
    Lab Invest; 1997 Jun; 76(6):835-42. PubMed ID: 9194859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of a model of human renin hypertension in rats].
    Bohlender J; Ménard J; Wagner J; Luft FC; Ganten D
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1009-11. PubMed ID: 8949369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional alterations in the left ventricle of three hypertensive rat models.
    Cerutti C; Kurdi M; Bricca G; Hodroj W; Paultre C; Randon J; Gustin MP
    Physiol Genomics; 2006 Nov; 27(3):295-308. PubMed ID: 16882881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of primary aldosteronism.
    Beuschlein F
    Horm Metab Res; 2010 Jun; 42(6):446-9. PubMed ID: 20013646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transition from experimental to clinical pharmacology: the renin-angiotensin paradigm.
    Ganten D
    J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S14-29. PubMed ID: 7507536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional genomics in hypertension.
    McBride MW; Graham D; Delles C; Dominiczak AF
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):145-51. PubMed ID: 16481881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.